DHX33 and malignant colon neoplasm: Previous research has shown that DHX33 is highly expressed in colon cancer tissues and cell lines, while its deficiency resulted in tumor growth retardation in colon cancer cells in an in vivo xenograft model (Wang et al., 2019a; Zhu et al., 2020).